VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50 | -31.5% | 4,523 | 0.0% | 0.00% | – |
| Q2 2023 | $73 | -5.2% | 4,523 | -2.0% | 0.00% | -100.0% |
| Q1 2023 | $77 | +92.5% | 4,617 | +9.3% | 0.00% | – |
| Q4 2022 | $40 | -99.7% | 4,226 | -1.4% | 0.00% | – |
| Q3 2022 | $12,000 | -14.3% | 4,284 | -9.1% | 0.00% | – |
| Q2 2022 | $14,000 | -22.2% | 4,711 | -21.6% | 0.00% | – |
| Q1 2022 | $18,000 | -5.3% | 6,009 | +47.7% | 0.00% | – |
| Q4 2021 | $19,000 | -20.8% | 4,069 | +1.7% | 0.00% | – |
| Q2 2021 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2021 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q4 2020 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q3 2020 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2020 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2020 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q4 2019 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q3 2019 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2019 | $24,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2019 | $24,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $2,613,000 | 6.32% |
| Opaleye Management Inc. | 825,000 | $14,371,000 | 3.66% |
| Prosight Management, LP | 274,410 | $4,780,000 | 2.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 859,727 | $14,976,000 | 1.72% |
| KNOTT DAVID M | 236,600 | $4,122,000 | 1.34% |
| Sio Capital Management, LLC | 213,252 | $3,715,000 | 1.28% |
| NEXTHERA CAPITAL LP | 327,730 | $5,709,000 | 1.09% |
| EAM Global Investors LLC | 115,781 | $2,017,000 | 0.82% |
| Nicholas Investment Partners, LP | 580,028 | $10,104,000 | 0.81% |
| Park West Asset Management LLC | 1,269,107 | $22,108,000 | 0.80% |